Kyrgyzstan digitalizes medicine tracking, monitoring 109 million packages

Kyrgyzstan is enhancing the traceability of medicines and medical devices through a comprehensive digitalization initiative, according to the Ministry of Health. A newly established state information system now provides digital tracking for the entire lifecycle of pharmaceutical products, from their import into the country and registration, all the way to the end consumer.

This system has already connected 2,604 participants, including 291 medical organizations and 2,313 pharmacies. It currently registers 2,075 different drug names and monitors a substantial volume of 109.2 million packages of medicines. A key component of this effort is the Dary-Darmek mobile application, designed to bolster patient safety, combat the proliferation of counterfeit medicines, and foster greater transparency within the pharmaceutical market.

As of June 30, 2026, the State Register of the Kyrgyz Republic officially listed 11,074 registered pharmaceutical products. Of these, approximately 6,300 are medicines, with 570 (9.1 percent) being domestically manufactured. The register also includes 4,800 medical devices, of which 90 (2 percent) are produced within Kyrgyzstan.

Despite these advancements, the report notes that the share of domestically produced medicines in Kyrgyzstan remains notably small, with up to 95 percent of medicines being imported from other countries. The digitalization drive aims to streamline processes and improve oversight in this largely import-dependent sector.